Laryngoscope market seen reaching $530 million by 2030

The Business Research Company says the global laryngoscope market will rise from $330 million in 2025 to $530 million by 2030, reflecting a 9.8% compound annual growth rate. The forecast points to growing demand for airway-management tools as respiratory disease cases, emergency care needs and video laryngoscope adoption increase.

Why it matters: - Laryngoscopes are central to airway management in surgery, emergency care and ventilator support. - The market outlook suggests steady demand for devices that help clinicians secure airways more safely and efficiently. - Rising respiratory disease burden adds pressure on hospitals and emergency services.

What happened: - The Business Research Company projected the global laryngoscope market will grow from $0.33 billion in 2025 to $0.36 billion in 2026. - The same forecast puts the market at $0.53 billion by 2030. - The report expects a 10.5% CAGR from 2025 to 2026 and a 9.8% CAGR from 2025 to 2030. - The forecast was published Aug. 13, 2026, in London. - The report is available as a free sample and as the full market report.

The details: - Laryngoscopes are specialized medical instruments used to examine the larynx and vocal cords. - The devices are used during tracheal intubation, especially for patients who need ventilator support. - The report ties past growth to more surgical procedures requiring intubation, better critical care infrastructure, wider anesthesia and ventilatory support use, optical visualization advances and broader hospital use. - Forward demand is linked to more sophisticated airway visualization tools, greater focus on difficult-airway management, growth in emergency medical services, and wider use of portable and wireless laryngoscopes. - The report also flags more investment in clinician training technology. - Emerging trends include video laryngoscopes, fiber-optic visualization, digital imaging systems, broader use in emergency and critical care settings and stronger airway-safety focus. - Respiratory diseases cited in the report include bronchitis, pneumonia, influenza and chronic obstructive pulmonary disease. - The report says laryngoscopes help diagnose dysphonia, laryngitis and laryngeal cancer. - The report also says laryngoscopes help seal airways for patients with infectious diseases such as tuberculosis, COVID-19 and Ebola to reduce aerosolization and transmission risk to healthcare workers. - Data from the Office for Health Improvement and Disparities showed a 7% rise in emergency hospital admissions for respiratory diseases in England between fiscal 2023 and fiscal 2024. - Asia-Pacific was the largest laryngoscope market in 2025. - North America ranked second. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market-hotspot infographics, and updated technology and trend analysis.

Between the lines: - The forecast suggests the category is being shaped less by one-off demand and more by a mix of clinical need, product innovation and infrastructure spending. - The emphasis on video, fiber-optic and digital systems points to a market moving toward more precise visualization and easier deployment in acute-care settings. - Asia-Pacific's lead likely reflects broader healthcare investment and expanding medical capacity, while North America remains a major market because of technology adoption.

What's next: - The market is expected to keep expanding through 2030 if respiratory disease pressure and emergency-care demand continue to rise. - Adoption of portable, wireless and video-based laryngoscopes is likely to be a key watch item. - Regional demand trends will matter most in Asia-Pacific and North America as providers upgrade airway-management tools.

The bottom line: - Laryngoscope demand is on track for solid mid-decade growth, driven by airway-management needs, respiratory illness and a shift toward more advanced visualization technology.